Alzheimer's disease → Carnitine palmitoyltransferase — Novel Hypothesis | InTree.AI

Novel Hypothesis

Alzheimer's diseaseCarnitine palmitoyltransferase

Carnitine palmitoyltransferase dysfunction impairs mitochondrial β-oxidation and neuronal energy metabolism in AD.

Convergence: 27%1 bridgemetabolism

Bridge Entities

CPT1AA→B quality: 0.70B→C quality: 0.70

Alzheimer's disease PARTICIPATES IN CPT1A, which CONNECTED TO Carnitine palmitoyltransferase

A→B Evidence (9 total)

“Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation.”— Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice. (2023)DOI

“Carnitine palmitoyltransferase 1A (CPT1A) deficiency is a rare disorder of hepatic long-chain fatty acid oxidation.”— A patient with atypical presentation of chronic hepatosteatosis harboring a novel variant in the CPT1A gene. (2020)DOI

Why This Is Novel

The Alzheimer's disease–Carnitine palmitoyltransferase connection is partially studied (74 co-occurrences), but the CPT1A-mediated mechanism may represent a less-explored angle within this relationship.

Discovered by InTree.AI — analyzing 250M+ scientific papers